Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by edroseon Nov 05, 2020 7:51am
125 Views
Post# 31840793

why doesn it take few years just to get four

why doesn it take few years just to get four4 checkpoints approved by fda it simply doesn't make sense     correspondance from fda will be interesting read and truth will come out 
also why they couldn't attract one potential buyer/partner also non sens as well as 'WE COULDN'T RAISE MONEY before takeover which is false since as soon as they wiped out retail investors they did rights offering and raised more than 30 million dollars   
<< Previous
Bullboard Posts
Next >>